OCGN
Ocugen Inc
NASDAQ: OCGN · HEALTHCARE · BIOTECHNOLOGY
$1.73
+2.98% today
Updated 2026-04-30
Market cap
$557.42M
P/E ratio
—
P/S ratio
126.31x
EPS (TTM)
$-0.23
Dividend yield
—
52W range
$1 – $3
Volume
8.9M
Ocugen Inc (OCGN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-12.23M | $-15.28M | $-18.41M | $-30.03M | $-25.74M | $-23.02M | $-15.78M | $-16.89M | $-14.71M | $-47.94M | $-60.08M | $-62.05M | $-42.14M | $-56.96M |
| Capital expenditures | $79000.00 | $604000.00 | $3.32M | $1.95M | $320000.00 | $276000.00 | $2.01M | $29446.00 | $306825.00 | $939000.00 | $4.46M | $10.48M | $3.38M | $185000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $14000.00 | $158000.00 | $547000.00 | $1.23M | $1.55M | $1.57M | $1.63M | $884089.00 | $660000.00 | $6.96M | $10.54M | $9.22M | $7.43M | $7.71M |
| Free cash flow | $-12.31M | $-15.89M | $-21.73M | $-31.98M | $-26.06M | $-23.30M | $-17.79M | $-16.92M | $-15.02M | $-48.88M | $-64.54M | $-72.53M | $-45.53M | $-57.15M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | $6.80M | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-27.61M | $993000.00 | $-24.83M | — | $5.82M | $16.60M | $70.92M | — | — | — | — |